Inflammation in adverse cardiac remodeling: Is there impact to gain?

Medicine & Life Sciences

• Growth Differentiation Factor 15 100%
• Inflammation 38%
• Anaphylatoxin C5a Receptor 30%
• Leukocytes 25%
• Peripheral Arterial Disease 21%
• Cardiovascular Diseases 18%
• Aortic Valve Stenosis 14%
• Heart Failure 9%
• Pressure 8%
• Amputation 6%
• Knockout Mice 6%
• Cicatrix 5%
• Infarction 5%
• Myocardium 5%
• Monocytes 5%
• Cause of Death 5%
• Neutrophils 5%
• Spleen 5%
• Hemodynamics 4%
• Lymph Nodes 4%
• Hypertension 4%
• Heart 4%
• Delivery of Health Care 3%
• Mortality 3%
• Proteins 2%